We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
It was something of an up-and-down week for IPOs: Two biotechs, Alzheimer’s focused Alzheon and brittle bone drug company Mereo BioPharma pulled their ...
Noting that General Electric had an awful year in 2017, losing 44.8 percent of its stock value, Boston Business Journal took a look at the state’s biggest stock losers.